The following video clips are highlights from the 2022 ESSKA Consensus on the Use of Injectable Orthobiologics for Knee Osteoarthritis, Part 1 - Blood-derived Products (PRP).
Clip downloads can be ordered from the ON Foundation office.
What is the motivation behind the ORBIT consensus project?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
Which Methodology did the consensus team use?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
How does the consensus team define "Blood Derived Products"?
Speaker: Laura de Girolamo
Publication: ESSKA ORBIT Consensus Report
Does current clinical evidence support the use of PRP for knee OA?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
For which degrees of knee OA is PRP best indicated?
Speaker: Giuseppe Filardo
Publication: ESSKA ORBIT Consensus Report
Is PRP indicated for the treatment of Patellofemoral OA (PFOA)?
Speaker: Laura de Girolamo
Publication: ESSKA ORBIT Consensus Report
For what age range is PRP recommended?
Speaker: Elizaveta Kon
Publication: ESSKA ORBIT Consensus Report
Could PRP for knee OA be used during the inflammatory phase when joint effusion is present (following effusion aspiration)?
Speaker: Thomas Tischer
Publication: ESSKA ORBIT Consensus Report
Is a repeated cycle of PRP injections recommended following a previous successful PRP treatment for knee OA upon the re-emergence of symptoms?
Speaker: Mikel Sanchez
Publication: ESSKA ORBIT Consensus Report
Is there rationale in injecting PRP in asymptomatic early knee OA?
Speaker: Elizaveta Kon
Publication: ESSKA ORBIT Consensus Report
Are there advantages of PRP use in comparison to Corticosteroids for treating knee OA?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
Is PRP a clinically better injectable option than hyaluronic acid for the treatment of knee OA?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
Does PRP induce disease-modifying effects in knee OA?
Speaker: Giuseppe Filardo
Publication: ESSKA ORBIT Consensus Report
Which PRP is preferred for knee OA: Leukocyte-Rich PRP (LR-PRP) or Leukocyte-Poor PRP (LP-PRP)?
Speaker: Laura de Girolamo
Publication: ESSKA ORBIT Consensus Report
What is the recommended platelet number/concentration range for PRP injections in knee OA?
Speaker: Laura de Girolamo
Publication: ESSKA ORBIT Consensus Report
What is the recommended volume of PRP to inject into a knee for the treatment of knee OA?
Speaker: Thomas Tischer
Publication: ESSKA ORBIT Consensus Report
How many injections of PRP are recommended for the treatment of knee OA?
Speaker: Lior Laver
Publication: ESSKA ORBIT Consensus Report
When using a treatment protocol with more than one injection for knee OA, what is the recommended interval between each injection of PRP?
Speaker: Rodica Marinescu
Find Publication: ESSKA ORBIT Consensus Report
Are non steroidal anti-inflammatory drugs (NSAIDs) allowed around PRP use?
Speaker: Baris Kocaoglu
Publication: ESSKA ORBIT Consensus Report
Should intra-articular local anesthetics be used when injecting PRP?
Speaker: Ramon Cugat
Publication: ESSKA ORBIT Consensus Report
Is Antibiotics administration recommended around PRP use?
Speaker: Ramon Cugat
Publication: ESSKA ORBIT Consensus Report
Is fasting recommended before PRP use? Is there any other patient behaviour that could affect the treatment?
Speaker: Rodica Marinescu
Publication: ESSKA ORBIT Consensus Report
Does PRP and HA have a synergistic effect?
Speaker: Michael Iosifidis
Publication: ESSKA ORBIT Consensus Report
Is there any synergy between PRPs and cell-based therapies for knee OA?
Speaker: Laura de Girolamo
Publication: ESSKA ORBIT Consensus Report
There was a problem while submitting your data. Please try again later.
